Richard Wesseloo

Richard Wesseloo is a researcher at Erasmus MC's Psychiatry department, focusing on the intersection of psychiatric treatment during pregnancy and neonatal outcomes. His work bridges pharmacology, obstetrics, and perinatal mental health.

• Primary affiliation: Erasmus MC, Department of Psychiatry
• Research themes: Bipolar disorder management, lithium pharmacokinetics during pregnancy, and fetal growth outcomes

Wesseloo's research explores the dose-response relationships of psychiatric medications like lithium and lamotrigine during pregnancy, examining impacts on birth weight, fetal growth, and neonatal health. He employs cohort studies and observational methodologies to address critical gaps in perinatal psychopharmacology.

Recent publications highlight his contributions to understanding lithium's teratogenic risks and lamotrigine's efficacy in bipolar disorder. His work has been cited in clinical guidelines and social media, reflecting practical and academic impact.

Collaborations with experts like Prof. Bergink and Dr. Poels span cross-institutional partnerships. While specific awards or student advising details aren't listed, his research outputs demonstrate sustained engagement in translational mental health studies.